The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Control of cell cycle progression by c-Jun is p53 dependent
Open accessAbstract
The c-jun proto-oncogene encodes a component of the mitogen-inducible immediate-early transcription factor AP-1 and has been implicated as a positive regulator of cell proliferation and G1-to-S-phase progression. Here we report that fibroblasts derived from c-jun-/- mouse fetuses exhibit a severe proliferation defect and undergo a prolonged crisis before spontaneous immortalization. The cyclin D1- and cyclin E-dependent kinases (CDKs) and transcription factor E2F are poorly activated, resulting in inefficient G1-to-S-phase progression. Furthermore, the absence of c-Jun results in elevated expression of the tumor suppressor gene p53 and its target gene, the CDK inhibitor p21, whereas overexpression of c-Jun represses p53 and p21 expression and accelerates cell proliferation. Surprisingly, protein stabilization, the common mechanism of p53 regulation, is not involved in up-regulation of p53 in c-jun-/- fibroblasts. Rather, c-Jun regulates transcription of p53 negatively by direct binding to a variant AP-1 site in the p53 promoter. Importantly, deletion of p53 abrogates all defects of cells lacking c-Jun in cell cycle progression, proliferation, immortalization, and activation of G1 CDKs and E2F. These results demonstrate that an essential, rate-limiting function of c-Jun in fibroblast proliferation is negative regulation of p53 expression, and establish a mechanistic link between c-Jun-dependent mitogenic signaling and cell-cycle regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 5×
“The core cell cycle clock itself operates by sequential activation and inactivation of a number of protein kinase complexes known as CDKs (Harper and Elledge 1996; Sherr 1996).”
BackgroundInfluentialThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · cited 4×
“…consist of cyclin D1, D2, or D3 associated with CDK4 or CDK6 and cyclin E–CDK2 and phosphorylate, among others, the retinoblastoma protein (pRb) (Weinberg 1995). pRb phosphorylation leads to release of transcription factor E2F, which, once liberated, triggers expression of genes that enable…”
InfluentialInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,931
Self-citationTodaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,736
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Self-citationTumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Verheij, M., Bose, R., Hua Lin, X., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., et al. (1996) · Nature · doi:10.1038/380075a0 · Cited by 1,767
Cited by
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
Self-citationAP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Self-citationAP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
Self-citationRequirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Mitogen-activated protein kinases in apoptosis regulation
Wada, T., & Penninger, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207556 · Cited by 1,432
AP-1 subunits: quarrel and harmony among siblings
Hess, J., Angel, P., & Schorpp-Kistner, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01589 · Cited by 1,302
Self-citationA comprehensive pathway map of epidermal growth factor receptor signaling
Oda, K., Matsuoka, Y., Funahashi, A., & Kitano, H. (2005) · Molecular Systems Biology · doi:10.1038/msb4100014 · Cited by 1,158
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K.-M. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 800
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 756
Sun, S., Sprenger, C. C. T., Vessella, R. L., Haugk, K., Soriano, K., Mostaghel, E. A., Page, S. T., Coleman, I. M., Nguyen, H. M., Sun, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41824 · Cited by 748
AP-1 in mouse development and tumorigenesis
Jochum, W., Passegué, E., & Wagner, E. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204389 · Cited by 733
Self-citationRegulation and function of the p53 tumor suppressor protein
Ryan, K. M., Phillips, A. C., & Vousden, K. H. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00216-7 · Cited by 721
The circadian clock: pacemaker and tumour suppressor
Fu, L., & Lee, C. C. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1072 · Cited by 678
“Genes that are directly or indirectly controlled by AP1 include Ccnd1, Trp53, Cdkn1a and Cdkn2a (Ref”
BackgroundIL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673
The cellular response to p53: the decision between life and death
Sionov, R. V., & Haupt, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203130 · Cited by 601
Targeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585
Mukherji, A., Kobiita, A., Ye, T., & Chambon, P. (2013) · Cell · doi:10.1016/j.cell.2013.04.020 · Cited by 560
Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
Leppä, S., & Bohmann, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203173 · Cited by 522
“…the molecular mechanisms underlying c-Jun-dependent growth control have not completely been resolved yet, one plausible mechanism by which c-Jun could positively regulate cell cycle progression was described recently and found to involve the tumor suppressor gene p53 (Schreiber et al., 1999).”
BackgroundMielke, K., & Herdegen, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00042-8 · Cited by 490
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.-P., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 474
Self-citationThe complexity of mitogen-activated protein kinases (MAPKs) made simple
Krishna, M., & Narang, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8170-7 · Cited by 432
c-Jun and JunB Antagonistically Control Cytokine-Regulated Mesenchymal–Epidermal Interaction in Skin
Szabowski, A., Maas-Szabowski, N., Andrecht, S., Kolbus, A., Schorpp-Kistner, M., Fusenig, N. E., & Angel, P. (2000) · Cell · doi:10.1016/s0092-8674(00)00178-1 · Cited by 428
Self-citationRauch, A., Seitz, S., Baschant, U., Schilling, A. F., Illing, A., Stride, B., Kirilov, M., Mandic, V., Takacz, A., Schmidt-Ullrich, R., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.005 · Cited by 422
Self-citationBakiri, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.2056 · Cited by 398
Distinct Roles for JNK1 and JNK2 in Regulating JNK Activity and c-Jun-Dependent Cell Proliferation
Sabapathy, K., Hochedlinger, K., Nam, S. Y., Bauer, A., Karin, M., & Wagner, E. F. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.028 · Cited by 396
Self-citationMathas, S., Hinz, M., Anagnostopoulos, I., Krappmann, D., Lietz, A., Jundt, F., Bommert, K., Mechta‐Grigoriou, F., Stein, H., Dörken, B., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf389 · Cited by 375
Chang, L., Jones, Y., Ellisman, M. H., Goldstein, L. S. B., & Karin, M. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00094-7 · Cited by 374
Self-citationIntracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21
McEwan, W. A., Tam, J. C. H., Watkinson, R. E., Bidgood, S. R., Mallery, D. L., & James, L. C. (2013) · Nature Immunology · doi:10.1038/ni.2548 · Cited by 372
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H., & Wagner, E. F. (2007) · Nature Genetics · doi:10.1038/ng2033 · Cited by 352
Self-citationEmerging roles of ATF2 and the dynamic AP1 network in cancer
Lopez-Bergami, P., Lau, E., & Ronai, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2681 · Cited by 350
The mammalian Jun proteins: redundancy and specificity
Mechta-Grigoriou, F., Gerald, D., & Yaniv, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204381 · Cited by 340
Activation of the p53 tumor suppressor protein
Vousden, K. H. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00035-5 · Cited by 337
JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression
Passegue, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2969 · Cited by 332
A role for AP-1 in apoptosis: the case for and against
Ameyar, M., Wisniewska, M., & Weitzman, J. B. (2003) · Biochimie · doi:10.1016/j.biochi.2003.09.006 · Cited by 330
Transcriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 324
Woods, D. B., & Vousden, K. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5141 · Cited by 319
Genome-wide studies highlight indirect links between human replication origins and gene regulation
Cadoret, J.-C., Meisch, F., Hassan-Zadeh, V., Luyten, I., Guillet, C., Duret, L., Quesneville, H., & Prioleau, M.-N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805208105 · Cited by 313
Molecular mechanisms of hepatic fibrogenesis
Parsons, C. J., Takashima, M., & Rippe, R. A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04659.x · Cited by 310
Cell Cycle Control of Embryonic Stem Cells
White, J., & Dalton, S. (2005) · Stem Cell Reviews · doi:10.1385/scr:1:2:131 · Cited by 310
Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1): Miniperspective
Ye, N., Ding, Y., Wild, C., Shen, Q., & Zhou, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5004733 · Cited by 307
Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00193-8 · Cited by 295
Self-citationHDAC4, a Human Histone Deacetylase Related to Yeast HDA1, Is a Transcriptional Corepressor
Wang, A. H., Bertos, N. R., Vezmar, M., Pelletier, N., Crosato, M., Heng, H. H., Th’ng, J., Han, J., & Yang, X.-J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7816 · Cited by 294
The functional contrariety of JNK
Bode, A. M., & Dong, Z. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20348 · Cited by 293
Vogt, P. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204443 · Cited by 289
Control of the eukaryotic cell cycle by MAP kinase signaling pathways
Wilkinson, M. G., & Millar, J. B. A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0102rev · Cited by 280
c-Jun Regulates Eyelid Closure and Skin Tumor Development through EGFR Signaling
Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M., & Wagner, E. F. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00161-8 · Cited by 279
Self-citationA model of transcriptional regulatory networks based on biases in the observed regulation rules
Harris, S. E., Sawhill, B. K., Wuensche, A., & Kauffman, S. (2002) · Complexity · doi:10.1002/cplx.10022 · Cited by 277
Functions of c-Jun in Liver and Heart Development
Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E. F., & Zatloukal, K. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.5.1049 · Cited by 275
Self-citationBehrens, A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1782 · Cited by 270
JunD Protects Cells from p53-Dependent Senescence and Apoptosis
Weitzman, J. B., Fiette, L., Matsuo, K., & Yaniv, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00109-x · Cited by 269
Regulation of cellular functions by the ERK5 signalling pathway
Wang, X., & Tournier, C. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.11.003 · Cited by 264
Courtois, S., Verhaegh, G., North, S., Luciani, M.-G., Lassus, P., Hibner, U., Oren, M., & Hainaut, P. (2002) · Oncogene · doi:10.1038/sj.onc.1205874 · Cited by 263
Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9588-7 · Cited by 255
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Stepniak, E., Ricci, R., Eferl, R., Sumara, G., Sumara, I., Rath, M., Hui, L., & Wagner, E. F. (2006) · Genes & Development · doi:10.1101/gad.390506 · Cited by 232
“It has been demonstrated that c-Jun is a repressor of p53 in immortalized fibroblasts and liver cancer cells, and consequently, the levels of p53 protein are increased in both cell types when c-Jun is absent (Schreiber et al. 1999; Eferl et al. 2003).”
BackgroundInfluentialSelf-citationJunB can substitute for Jun in mouse development and cell proliferation
Passegué, E., Jochum, W., Behrens, A., Ricci, R., & Wagner, E. F. (2002) · Nature Genetics · doi:10.1038/ng790 · Cited by 162
“In turn, increased p21 expression is responsible for the slow proliferation, premature senescence and prolonged ultraviolet-induced cell-cycle arrest of immortalized Jun -deficient cell”
BackgroundSelf-citationPdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
Yang, H.-S., Knies, J. L., Stark, C., & Colburn, N. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206433 · Cited by 160
The JNK Are Important for Development and Survival of Macrophages
Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T., & Hume, D. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2219 · Cited by 117
Takakura, M., Kyo, S., Inoue, M., Wright, W. E., & Shay, J. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8037-8043.2005 · Cited by 107
Ehyai, S., Dionyssiou, M. G., Gordon, J. W., Williams, D., Siu, K. W. M., & McDermott, J. C. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00832-15 · Cited by 32
“c-Jun fulfills a prominent cellular role as part of the activator protein 1 (AP-1) complex, which is known to promote cell proliferation by its induction of cyclin D1 (44) and downregulation of p53 (45).”
BackgroundHdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells
Sui, X., Shin, S., Zhang, R., Firozi, P. F., Yang, L., Abbruzzese, J. L., & Reddy, S. A. G. (2009) · Oncogene · doi:10.1038/onc.2008.423 · Cited by 25
Repression of the RHOH gene by JunD
Delestré, L., Berthon, C., Quesnel, B., Figeac, M., Kerckaert, J.-P., Galiègue-Zouitina, S., & Shelley, C. S. (2011) · Biochemical Journal · doi:10.1042/bj20100829 · Cited by 13
(2000) · doi:10.1002/1097-0215(20001015)88:2<157::aid-ijc2>3.0.co;2-b
Metadata
- Authors
- Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., & Wagner, E. F.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-03-01
- Volume
- 13
- Issue
- 5
- Pages
- 607-619
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2146035452
- Cited by
- 574
- References
- 64
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.